Objective: To clarify the influence of nutritional route on hepatic immunity in a murine model. Summary Background Data: Parenteral nutrition is disadvantageous for preventing infectious complications in critically ill and/or severely injured patients as compared with enteral nutrition. To date, lack of enteral nutrition has been demonstrated to impair mucosal immunity, gut barrier function, and the peritoneal defense system. However, influences of nutritional route on hepatic immunity, another important defense system against infection, have not been well studied. Methods: Male ICR mice were randomized to 3 groups: ad libitum chow (chow), intravenous (IV)-TPN and intragastric (IG)-TPN groups. The TPN groups were given isocaloric and isonitrogenous TPN solutions. After the mice had been fed for 5 days, hepatic mononuclear cells (MNCs) were isolated. Hepatic MNC numbers and functions (cytokine production, intracellular signaling, and LPS receptor expression) were determined. Moreover, 1.0 ϫ 10 7 Pseudomonas aeruginosa were delivered by intraportal injection. Survival and histology were examined. Results: Hepatic MNC numbers were significantly lower in the IV-TPN group than in the chow and IG-TPN groups, without subpopulation changes. As compared with enterally fed mice, cytokine production (TNF-␣, IFN-␥, and IL-10) by hepatic MNCs in response to LPS was impaired in parenterally fed mice in association with blunted phosphorylation of ERK1/2, a MAPK. Hepatic MNCs from IV-TPN mice showed decreased expressions of CD14 and TLR4/MD2, as compared with enterally fed mice. Survival times were reduced in the IV-TPN group as compared with the chow and IG-TPN groups. Conclusion: Preservation of hepatic immunity with enteral feeding is important for prevention of infectious complications in severely injured and/or critically ill patients. (Ann Surg 2007;245: 642-650) P arenteral nutrition (PN) is essential for preventing pro-
gressive malnutrition in patients who cannot receive enteral nutrition due to intolerance or bowel obstruction. However, clinical observations have demonstrated PN to be disadvantageous as compared with enteral nutrition for preventing infectious complications in critically ill and/or severely injured patients. [1] [2] [3] In recent decades, the mechanisms underlying compromised host defense during absence of enteral nutrition have been extensively investigated in terms of gut barrier function, respiratory tract immunity, and the peritoneal defense system. 4 -7 Long-term PN has been demonstrated to be associated with liver dysfunction. 8, 9 PN induces hepatic-steatosis, decreases bile flow and hepatic secretory function, and impairs albumin synthesis and drug conjugation. However, to our best knowledge, no studies have examined the impact of nutritional route on hepatic immunity.
The liver plays an important role in the innate immune response, providing a first line of defense against intestinal microbes and toxins crossing the intestinal barrier. 10, 11 The liver contains a significant number of mononuclear cells (MNCs). Kupffer cells are resident hepatic macrophages that constantly clear bacteria and toxins from the peripheral circulation. When activated in response to bacterial endotoxins, Kupffer cells produce various pro-inflammatory cytokines and phagocytose the pathogens. Hepatic MNCs also include both resident and liver-infiltrating natural killer, T and B cells. This combination of antigen-presenting cells and lymphocyte populations indicates that the liver has a central role in the immune system, capable of responding to and eliminating pathogenic microorganisms and toxins. Because the main blood supply to the liver is via the portal vein and lack of enteral nutrient delivery changes gut barrier function, we hypothesized that PN would impair hepatic MNC function, which may also be an important mechanism for increased susceptibility to infectious complications. Thus, in the present study, we examined the influence of nutritional route on hepatic MNC function and number in a murine model. Cytokine production (TNF-␣, IFN-␥, and IL-10) in response to lipopolysaccharide (LPS), phosphorylation of a MAPK (mitogen-activated protein kinase), ERK1/2 (extracellular signalregulated kinase), and expression of LPS receptors (CD14 and TLR4/MD2), were analyzed using the MNCs (Fig. 1 ). 12 Finally, resistance to a gram-negative bacterial challenge, delivered via the portal vein, was observed.
MATERIALS AND METHODS

Animals
The studies described herein conform to the guidelines for the care and use of laboratory animals established by the Animal Use and Care Committee of the National Defense Medical College. Male Institute of Cancer Research (ICR) mice, 6 to 7 weeks of age, were purchased from Japan SLC Inc (Hamamatsu, Japan). The mice were housed under controlled temperature and humidity conditions with a 12-hour/ 12-hour light:dark cycle. For acclimation, mice were fed commercial mouse chow (CE7, CLEA, Japan) with water ad libitum for 1 week before protocol entry.
Surgical Procedure
After the mice had been fasted overnight, they were given general anesthesia (ketamine 100 mg/kg and xylazine 10 mg/kg mixture). After randomization to chow (n ϭ 53), intravenous-TPN (IV-TPN) (n ϭ 48), or intragastric-TPN (IG-TPN) (n ϭ 41), mice in the chow and IV-TPN groups underwent implantation of silicon rubber catheters (0.3 mm ID and 0.5 mm OD; Imamura Co. Tokyo, Japan) into the right jugular vein with sham laparotomy, while gastrostomy was achieved with a silicon rubber tube (Imamura Co. 0.4 mm ID and 0.6 mm OD) in the IG-TPN group with sham neck incision. The proximal end of the catheter was tunneled subcutaneously over the spine and exited the tail at its midpoint. After these procedures, the mice were placed in individual metal metabolism cages and partially immobilized by tail restraint to protect the catheter during infusion. This technique is a well-established method of nutritional support that induces neither physical nor biochemical stress. 13 All procedures were performed aseptically. Catheterized mice were immediately connected to infusion pumps (TE331; Terumo, Tokyo, Japan).
Nutritional Support
The experimental protocol is shown in Figure 2 . Catheterized mice received 0.9% saline at 0.2 mL/hr for 48 hours with ad libitum access to chow (CE7) and water for recovery from surgical stress. The chow group served as controls and continued to receive a 0.9% NaCl solution intravenously with free access to chow and water throughout the study period. On postoperative day 2, the IV-and IG-TPN mice received their standard TPN solutions. The IV-and IG-TPN mice were advanced from 0.2 mL/hr of TPN solution to the final goal of 0.4 mL/hr (85.8 kJ/day) by the third day of feeding, because a graded infusion period is necessary to allow the mice to adapt to the glucose and fluid loads. 14 This TPN solution provided 5955.6 KJ/L with a nonprotein Joulenitrogen ratio of 871.0:1. 15 TPN solution is supplemented with micronutrients (Elemenmic, Ajinomoto, Tokyo, Japan) and multivitamins (M.V.I-SS, SS-seiyaku Co., Tokyo, Japan). 15 The TPN solution was prepared aseptically, without endotoxin contamination.
Experiment 1: Hepatic MNC Study
Isolation of Hepatic MNCs
After being fed for 5 days, all mice were anesthetized (ketamine 100 mg/kg and xylazine 10 mg/kg mixture) and exsanguinated by cardiac puncture. Liver MNCs were obtained as previously described. 16 Briefly, the harvested liver 
Subpopulation and In Vitro Cytokine Production
Thirty mice were fed chow (n ϭ 10), IV-TPN (n ϭ 10), or IG-TPN (n ϭ 10) for 5 days and hepatic MNCs were isolated. The hepatic MNC subpopulation was analyzed with Wright-Giemsa staining and flow cytometry. Phenotypes of the MNCs were identified using monoclonal antibodies in conjunction with the two-color immunofluorescence test. 10 6 cells were suspended in 50 L of HBSS containing fluorescein isothiocyanate (FITC) antimouse CD3 (clone 145-2C11;BD Bioscienences, San Jose, CA) and phycoerythrin (PE) conjugated antimouse NK cells (cloneDX5;Caltag, Burlingame, CA) to identify T cells and NK cells, respectively, or FITC-anti-CD45R (clone RA3-6B2;Caltag) and PE-antimouse F4/80 (clone CI;A3-1Caltag) to identify B cells and Kupffer cells. All antibodies were diluted to 1 g/mL in HBSS containing 1% FBS. Incubations were carried out for 30 minutes on ice, in the shade. After staining, the cells were washed twice in HBSS/1% and flow-cytometric analysis was then performed on an Epics XL (Coulter, Hialeah, IL). After counting the cells, 5 ϫ 10 5 MNCs in 200 L of 10% FBS RPMI 1640 medium were cultured in 96 well flat-bottomed plates with or without LPS (0, 100, 1000 ng/mL) in 5% CO 2 at 37°C for 4 hours. Finally, the culture supernatant was collected and frozen at Ϫ80°C. TNF-␣, IFN-␥, and IL-10 levels in the culture supernatant were measured using ELISA kits (Endogen, Inc, Boston, MA).
ERK Phosphorylation
Twenty-five mice (chow, n ϭ 7; IV-TPN, n ϭ 10; IG-TPN, n ϭ 8) were used for measurement of ERK1/2 phosphorylation in hepatic MNCs. We measured ERK1/2 phosphorylation using flow cytometry and laser scanning cytometry (LSC101; Olympus, Tokyo, Japan). 17 The MNCs were incubated with 0, 100, or 1000 ng/mL of LPS (from E. coli serotype O111:B4 Sigma), for 30 minutes at 37°C. The MNCs were washed with PBS containing 0.1% BSA and fixed using 2% formaldehyde for 10 minutes. Then, the cells were washed and permeabilized in 100% methanol for 3 minutes. The MNCs were washed in PBS containing 0.1% BSA and incubated in blocking buffer (20% normal goat serum in PBS with 0.1% BSA) for 45 minutes at room temperature. For detection of phosphorylated ERKs, cells were incubated with antiphospho-p42/44 MAPK antibodies (1:100; Cell Signaling, Danvers, MA) in PBS with 0.1% BSA for 50 minutes at room temperature. After washing in PBS with 0.1% BSA, cells were incubated with an Alexa 488conjugated secondary antibody (goat anti-rabbit IgG; Molecular Probes, Eugene, OR) diluted 1:500 in PBS with 0.1% BSA. In each sample, flow cytometric analysis was performed using Epics XL. The results of ERK1/2 phosphorylation in MNCs were expressed as mean fluorescence intensity (MFI). The cells were photographed with a cooled CCD digital camera (Sensys1400; Olympus) adapted to the LSC microscope. The samples were incubated with 50 mg/mL propidium iodide (PI; Sigma) solution and 200 mg/mL ribonuclease A (Sigma) for 10 minutes. Photographs of the cells were taken with the LSC.
LPS Receptor Expressions
Forty-one mice (chow, n ϭ 15; IV-TPN, n ϭ 15; IG-TPN, n ϭ 11) were used to determine CD14 and TLR4/ MD2 membrane protein expressions by flow-cytometric analysis. Isolated MNCs were incubated with 1 L of FITC conjugated anti-CD14 antibody (clone rmC5-3; BD Biosciences) and PE conjugated anti-F4/80 (Caltag) for 30 minutes at 4°C. Hepatic MNCs were incubated with 1 L of biotinylated conjugated anti-TLR4/MD2 antibody (clone MTS510; eBioscience, San Diego, CA) for 30 minutes at 4°C. After being washed twice, the cells were incubated with 1 L of PE-conjugated anti-F4/80 (Caltag) and 1 L of FITC-conjugated streptavidin for 30 minutes at 4°C. F4/80 is a marker of Kupffer cells in hepatic MNCs. After being washed twice in HBSS/1% FBS, the cells were analyzed using a flowcytometer. CD14 and TLR4/MD2 expressions on F4/80-positive cells were evaluated in terms of MFI.
Experiment 2: Sepsis Model Preparation of Bacteria
Live Pseudomonas aeruginosa (American Type Culture Collection 27853) was used for induction of sepsis. P. aeruginosa was cultured in a brain-heart infusion broth (Becton Dickinson, Sparks, MD) for 24 hours at 37°C. The culture was centrifuged at 3000 rpm for 10 minutes at 4°C to pellet the P. aeruginosa, washed twice, and resuspended in sterile normal saline. A 100-L suspension was serially diluted with sterile saline, plated on sheep blood agar plates (Kanto Kagaku, Tokyo, Japan), and incubated for 18 hours for determination of the bacterial concentration. The remainder was stored at 4°C until use. Just before use, the bacterial suspension was adjusted to 5.0 ϫ 10 7 /mL. Our preliminary experiments using mice fed chow revealed that intraportal injection of 1.0 ϫ 10 8 P. aeruginosa was fatal for all mice within 48 hours, whereas no mortality was observed after 1.0 ϫ 10 6 injecting P. aeruginosa. Therefore, in the present study, the mice were challenged via the portal vein with 1.0 ϫ 10 7 P. aeruginosa.
Survival Study
After receiving their respective diets for 5 days, the mice (chow, n ϭ 18; IV-TPN, n ϭ 10; IG-TPN, n ϭ 9) were anesthetized with ketamine and xylazine, and a midline laparotomy was performed. P. aeruginosa (1.0 ϫ 10 7 CFU) were injected into the portal vein using a 30-gauge needle under a microscope. The abdominal wall was closed after hemostasis had been confirmed by direct compression. Two hours before bacterial injection, half of the mice in the chow group (n ϭ 9) were given 6.5 mg/kg of an ERK1/2 inhibitor, PD98059 (Cell Signaling), intraperitoneally. We had confirmed that this dose of PD98059 decreases phosphorylation of ERK1/2 in hepatic MNCs and causes no mortality without additional bacterial challenge. Survival was observed in 37 mice (chow without PD98059, n ϭ 9; chow with PD98059, n ϭ 9; IV-TPN, n ϭ 10; IG-TPN, n ϭ 9) up to 7 days after injection.
Histology
Tissue sections of lung and liver specimens collected from another set of mice at 72 hours after injection were examined. Samples were fixed by immersion in 10% buffered formalin. For light microscopy, tissue samples were embedded in paraffin, sectioned, and stained with hematoxylin and eosin.
Statistical Analysis
All data are expressed as the mean Ϯ standard error of the mean for each group. The statistical significance was determined using the Friedmann test, analysis of variance (ANOVA) for repeated measure or ANOVA followed by the post hoc test of Fisher's protected least significant difference. The log-rank test was used for survival time comparison. Differences were considered significant at P Ͻ 0.05. All statistical calculations were performed with SPSS software for windows.
RESULTS
Experiment 1: Hepatic MNC Study Body Weight Change in Subpopulation and Cytokine Production Study
At the beginning of the experiment, there were no significant differences in body weight among the groups. However, after being fed for 5 days, the IV-and IG-TPN groups showed significant weight loss as compared with the chow group. There was no significant difference between the IV-and IG-TPN groups ( Table 1) .
Hepatic MNC Number
The number of hepatic MNCs was significantly decreased in the IV-TPN group, as compared with the chow and IG-TPN groups ( Table 2 ).
Subpopulation of MNCs
Wright-Giemsa staining indicated approximately 75% of MNCs to be lymphocytes, 25% Kupffer cells, in all 3 groups ( Table 2) . Flow-cytometric analysis revealed the phenotypes of hepatic MNCs. There were no significant differences in the percentages of T, B, NK or Kupffer cells among the 3 groups (Table 2 ).
Cytokine Production
Without LPS stimulation, culture supernatant TNF-␣ levels were significantly higher in the IV-TPN group than in either of the enteral groups. With LPS stimulation at 1000 ng/mL, IL-10 levels in the enteral groups were significantly higher than that of the IV-TPN group. TNF-␣ and IL-10 levels were increased in response to LPS in the chow and IG-TPN groups, but the increase was blunted in the parenterally fed mice (Fig. 3) . IFN-␥ levels were also significantly increased in the chow, but not the IV-TPN, group. In the IG-TPN group, IFN-␥ levels tended to increase in response to LPS, but the increase did not reach statistical significance.
ERK1/2 Phosphorylation
Representative fluorescent images of hepatic MNCs obtained by LSC are presented in Figure 4 . Nuclei were stained red with propidium iodide. Phosphorylated ERK1/2 was stained green. Without LPS stimulation, hepatic MNCs from the chow, IV-TPN, and IG-TPN groups showed only slight green fluorescence. After LPS stimulation, the chow and IG-TPN, but not the IV-TPN, groups showed markedly increased green fluorescence in nuclei and the cytoplasm (Fig. 4) .
We measured MFI of phosphorylated ERK1/2 flow cytometrically. Without LPS stimulation, the 3 groups had similar MFI. LPS stimulation significantly increased MFI in the chow and IG-TPN groups. However, no increase was observed in the IV-TPN group after LPS stimulation ( Fig. 5 ).
Expressions of CD14 and TLR4/MD2 on F4/80-Positive Cells
The expressions of both CD14 and TLR4/MD2 on F4/80 positive hepatic MNCs (Kupffer cells) were significantly decreased in the IV-TPN group, as compared with the chow and IG-TPN groups (Fig. 6 ).
Experiment 2: Sepsis Model Survival
The survival time of the IV-TPN group was significantly reduced as compared with those of the enterally fed groups. Survival rates at 168 hours (7 days) were 67%, 78% and 0% in the chow, IG-TPN and IV-TPN mice, respectively. The survival time of the chow mice treated with PD98059 was reduced as compared with those of the chow and IG-TPN groups (Fig. 7 ).
Histopathologic Changes
Parenterally fed mice showed severe tissue damage, while enterally fed mice showed only mild changes. Liver sections from the IV-TPN mice showed focal coagulation necrosis of hepatocytes in some areas. In the lungs of the IV-TPN mice, the histopathologic changes included accumulation of inflammatory cells and edema in the interstitial spaces, and the damage was extensive, with focal pneumonitis and microabscess (Fig. 8 ).
DISCUSSION
Because cytokines are essential for the prevention of microbial infection, we first examined hepatic MNC cytokine production in response to LPS. We clarified TNF-␣, IFN-␥, and IL-10 productions by hepatic MNCs in response to LPS to be impaired in parenterally fed mice, as compared with enterally fed mice. TNF-␣ has important protective functions in mediating host defenses against infection. Production of TNF-␣ by macrophages reportedly induces local effects, including vascular permeability, enhanced microbial killing, and increased migration of neutrophils and macrophages. 18, 19 Lack of normal TNF-␣ production in local infection can result in an impaired local inflammatory response or deficien- cies of pro-inflammatory cytokines, thereby predisposing patients to infection-related complications. Therefore, blunted TNF-␣ production by hepatic MNCs may impair host defense against pathogens and toxins reaching the liver. IFN-␥ is a representative T H 1 cytokine produced by T and NK cells. The production of IFN-␥ is also essential for host defense against microbial infections because IFN-␥ is a potent inducer of macrophage activity and enhances the LPS-triggered production of pro-inflammatory cytokines by monocytes and macrophages. 20 Therefore, blunted IFN-␥ production may also be an important mechanism underlying impaired host defense during absence of enteral nutrition. Clinically, long-term parenterally fed infants who have undergone surgery are susceptible to infectious complications, with impaired pro-inflammatory cytokine responses to bacterial challenge. 21 This phenomenon may be associated with reduced TNF-␣ and IFN-␥ production by hepatic MNCs.
Contrary to TNF-␣ and IFN-␥, IL-10 is one of the representative T H 2, anti-inflammatory cytokines produced by macrophages and T cells. IL-10 is known to mitigate excessive inflammatory responses triggered by pro-inflammatory cytokines, LPS, and other mediators. Reportedly, Kupffer cells protect against acute lung injury in a rat peritonitis model through IL-10 production. 22 Thus, the balanced T H 1 and T H 2 cytokine response observed in enterally fed mice appears to activate immune cells to help fight bacterial infection while preventing an excessive inflammatory response. However, without enteral nutrition, hepatic MNCs fail to respond to contamination by pathogens, thereby allowing overwhelming infection.
To elucidate possible mechanisms underlying the reduced cytokine production in the IV-TPN group, we examined the influence of nutritional route on ERK1/2 phosphorylation in hepatic MNCs. ERK1/2 is an important cellular signaling component that converts various extracellular signals into intracellular responses and its activation results in TNF-␣ cytokine production. 23, 24 Many studies have shown that LPS stimulates the ERK1/2 in monocytes/macrophages. Jiang et al demonstrated phosphorylation of ERK1/2 in Kupffer cells to peak at 30 minutes after LPS stimulation. 25 Thus, we chose a 30-minute incubation with LPS for visualization and quantification of ERK1/2 phosphorylation. We found significantly increased ERK1/2 phosphorylation in hepatic MNCs from enterally fed mice after LPS stimulation, whereas those from parenterally fed mice did not show markedly increased ERK1/2 phosphorylation. The patterns of ERK1/2 responses to LPS seemingly parallel cytokine production, implying that blunted ERK1/2 phosphorylation during parenteral nutrition may, at least partly, account for reduced cytokine production.
Changes in hepatic MNC subpopulations due to nutritional route could also affect their capacity for cytokine production. Therefore, we examined subpopulations with Wright-Giemsa staining and flow cytometry. However, there were no significant differences among the 3 groups with either method. Considering the marked hepatic MNC loss as well as cell function losses, hepatic immunity as a whole may be especially depressed in the IV-TPN group. In this study, we demonstrated hepatic MNCs from parenterally fed mice to have decreased CD14 and TLR4/ MD2 expressions, as compared with enterally fed mice. CD14 and TLR4/MD2 receptor expressions are critical for host defense because pattern recognition receptors of the TLR family expressed by macrophages provide a first line of defense against microbial invasion. Recent studies have shown that CD14 and TLR4/MD2 are expressed on Kupffer cells and that isolated Kupffer cells from normal mice can respond to low concentrations of LPS by producing TNF-␣. 26, 27 On the other hand, genetically engineered CD14-deficient mice are insensitive to LPS and TLR4 knockout mice have also been found to show LPS resistance. 28, 29 Previously, in macrophages derived from C3H/HeJ mice, a naturally occurring mutant line that does not express TLR4, ERK activities were reported to be refractory to LPS induction. 30 Moreover, hepatocytes from TLR4-null mice showed significantly lower ERK1/2 phosphorylation in response to LPS than those from control mice. 31 Thus, reduced expression of LPS receptors on hepatic MNCs may render the host immunocompromised and be an important mechanism underlying reduced cytokine production and blunted ERK phosphorylation.
Our present data do not shed light on possible mechanisms underlying reduced expression of LPS receptors during parenteral feeding. Nomura et al demonstrated reduced cell surface expression of TLR4 after LPS treatment in murine peritoneal macrophages, suggesting that LPS plays a role in down-regulating TLR4 expression. 32 Kupffer cells in parenterally fed mice might be chronically exposed to higher concentrations of LPS than those in enterally fed mice because bacterial translocation may have been enhanced in IV-TPN mice. 33 These results led us to speculate that chronic exposure to LPS might down-regulate LPS receptor expression on Kupffer cells in our model. In addition, CD14 and TLR4 expressions might be directly lowered by intravenous administration of TPN solutions. Okada et al demonstrated TPN solutions themselves to have direct effects on neutrophil phagocytosis and whole-blood cytokine productions in response to an in vitro bacterial challenge. 34 Interestingly, TNF-␣ production was increased at baseline in the IV-TPN mice, as compared with enterally fed mice. It is possible that hepatic MNCs in the IV-TPN group were relatively activated with bacterial translocation and produced more TNF-␣ at baseline. Increased TNF-␣ production at baseline might be associated with hepatic dysfunction during PN.
To examine whether changes in hepatic MNC function and number due to lack of enteral nutrition affect hepatic immunity, survival after portal injection of gram-negative bacteria was observed in experiment 2. P. aeruginosa in- jected into the portal vein are carried via liver sinusoids past Kupffer cells before passing through the systemic circulation. Reportedly, more than 95% of P. aeruginosa are cleared by the liver after portal injection. 35 In contrast, since particulates injected into the jugular vein are carried directly to the pulmonary circulation, clearance in the liver is assumed to be less than 35%. 36 Therefore, our intraportal injection model using P. aeruginosa is likely to reflect hepatic immunity. As we expected, IV-TPN mice had a shorter survival time than IG-TPN and chow mice, correlating with the results of experiment 1. It may be reasonable that resistance to P. aeruginosa, gram-negative bacteria frequently isolated from infectious foci in surgical patients, coincided with the cytokine response and ERK phosphorylation in hepatic MNCs because LPS, the stimulant we used in the present study, is the principal component of the outer membrane of gramnegative bacteria. Impaired clearance of bacteria and a blunted cytokine response induce spillover of bacteria and endotoxins into the systemic circulation and place vital remote organs at risk for sepsis-induced tissue damage. Indeed, histologic study revealed severe tissue damage in the lungs of the IV-TPN mice.
One of the possible limitations of the current study is the composition of the TPN solution. In clinical settings, TPN may be given with lipids to patients because lipid emulsions are an effective source of nonprotein calories during TPN administration. Cukier et al reported that, in a rat model, lipid-free TPN reduced hepatic macrophage numbers as compared with lipid-supplemented TPN. 37 However, the TPN solutions that we used in this study contained no lipids. Because types of fatty acids, such as -3 and -6, may have quite different impacts on host responses, we used fat-free TPN solution. Absence of lipid from the TPN solution resulted in a relatively high glucose concentration. Consequently, blood sugar levels might have been excessively elevated, which would have affected hepatic MNC function. However, according to our preliminary study, blood sugar levels in the present model ranged from 115 to 232 mg/dL (179 Ϯ 19 mg/dL), even in the IV-TPN group. Furthermore, IG-TPN maintained hepatic MNC number and function, despite the solution not containing lipids.
A body weight reduction in the IV-TPN and IG-TPN groups may call into question whether the present findings were related to malnutrition. Nonetheless, the IG-TPN animals, which lost just as much weight as the IV-TPN animals, preserved hepatic immunity. Plasma albumin levels were also comparable in the IV-TPN and IG-TPN groups (data not shown). In our preliminary study, we examined ERK phosphorylation of hepatic MNCs from chow mice that consumed the same calories as the TPN groups. ERK was normally phosphorylated in the pair-fed chow mice. Thus, nutritional route is critical for hepatic immunity preservation. There may be limitations of increasing the nutritional support with IV-TPN in terms of increasing the calories or volumes of infusion.
Our present study provides new knowledge regarding the impact of nutritional route on host defense against pathogens. Clinicians should choose the enteral route for nutritional therapy in severely injured or critically ill patients to preserve hepatic immunity, as well as mucosal immunity and the intraperitoneal defense system. However, some patients must receive TPN if their conditions, eg, bowel obstruction, paralytic ileus, short gut, severe pancreatitis, or fistula, do not allow enteral nutrition. New TPN formulas enhancing hepatic MNC number and function are needed for safer and more effective TPN therapy. Because standard TPN solutions lack important immunonutrients, such as glutamine, nucleotides, and -3 fatty acids, the effects of adding these immunonutrients to parenteral solution on hepatic immunity need to be studied.
CONCLUSION
We demonstrated that lack of enteral feeding decreased hepatic MNC number, as well as cytokine production by these MNCs, in association with reduced LPS receptor expressions and the subsequent blunting of ERK1/2 phosphorylation. These changes appear to result in poor survival and severe tissue damage after an intraportal bacterial challenge. The present study provides insights into the importance of nutrient administration route for immunologic defenses in critically ill and severely injured patients. Preservation of hepatic immunity with enteral feeding can enhance host resistance to infection. We recommend the use of enteral nutrition over parenteral nutrition, when feasible, for severely injured or critically ill patients.
